What is the primary age group affected by bronchiolitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bronchiolitis Primarily Affects Children Under 2 Years of Age

Bronchiolitis primarily affects infants and young children between 1 month and 23 months of age, with the highest risk in those less than 12 months old, particularly infants younger than 12 weeks. 1

Age Distribution

  • Bronchiolitis is the most common lower respiratory infection in young children and the most common cause of hospitalization in those aged less than 1 year 1
  • The American Academy of Pediatrics (AAP) specifically defines the target population for bronchiolitis management as children from 1 month through 23 months of age 1
  • Approximately 90% of children are infected with Respiratory Syncytial Virus (RSV), the most common cause of bronchiolitis, within the first 2 years of life 1, 2
  • Most hospitalizations for bronchiolitis occur in infants less than 1 year old 1, 3

Age-Related Risk Factors

  • Infants younger than 12 weeks are at significantly higher risk for severe disease 4, 1
  • The highest hospitalization rates are seen in infants under 3 months of age 3
  • More than 50% of bronchiolitis-related deaths occur in patients younger than 3 months 3
  • The hospitalization rate for bronchiolitis for children under 1 year of age is approximately 3,838 per 100,000 healthy children 3

Clinical Presentation by Age Group

  • In infants 1-12 months:

    • More likely to present with increased work of breathing, including tachypnea, nasal flaring, and intercostal retractions 1
    • Higher risk of apnea, particularly in those younger than 1 month and in premature infants 1
    • More severe disease presentation compared to older children 5
  • In children 12-24 months:

    • Typically presents with rhinitis and cough that may progress to wheezing and rales 1
    • Generally better able to compensate for increased respiratory effort than younger infants 1
    • Less severe disease presentation 5

High-Risk Groups Within This Age Range

  • Premature infants, especially those born before 32 weeks gestation 1
  • Children with hemodynamically significant congenital heart disease 1, 2
  • Children with chronic lung disease of prematurity 1, 2
  • Children with neuromuscular disease or immunodeficiency 1
  • Infants with birth weight under 1500 grams 5
  • Non-exclusively breastfed infants 5

Clinical Course

  • Bronchiolitis is typically self-limiting, with most children recovering within 2-3 weeks 1
  • The mean time to cough resolution is 8-15 days 1
  • 90% of children are cough-free by day 21 1
  • Children with persistent symptoms beyond 4 weeks may represent a different clinical problem, sometimes termed "post-bronchiolitis syndrome" 1

Important Considerations

  • Neonates (under 1 month) with bronchiolitis symptoms require special consideration due to their higher risk of severe disease and apnea 1
  • The AAP guidelines specifically exclude children with immunodeficiencies, underlying respiratory illnesses, neuromuscular disease, or hemodynamically significant congenital heart disease from general management recommendations 1
  • Children outside the 1-24 month age range may develop bronchiolitis-like illnesses but may have different clinical presentations, management needs, and outcomes 1

References

Guideline

Bronchiolitis in Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Respiratory Syncytial Virus Infection in Infants and Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.